|
|
|
|
|
02.11.26 - 08:18
|
Morten Henneveld appointed interim CEO of Atlas Antibodies (Cision)
|
|
|
The Board of Atlas Antibodies and Dan Pitulia have mutually agreed that Dan will leave his position as the CEO of the Atlas Antibodies Group.
Morten Henneveld has assumed the role of interim CEO as of November 1, 2026. Morten was most recently CEO of OssDsign and prior to that held leadership positions at GN Group, Zimmer Biomet and Coloplast.
“We thank Dan for his leadership, and we look forward to partnering with Morten and the team as we embark on the next chapter together. His extensive leadership experience and track record of driving strategic change will be instrumental...
|
|
|
29.10.26 - 09:06
|
Coloplast opens new factory in Portugal to support global growth (GlobeNewswire EN)
|
|
|
Coloplast today inaugurates its largest manufacturing site to date, a two-floor 50,000 m2 facility in Felgueiras, Portugal, expanding the company's production capacity to meet growing global demand for continence care products, while supporting the company's long-term ambition of helping four million people worldwide. ...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.06.26 - 19:48
|
Jette Nygaard-Andersen Joins LivaNova Board as a New Director (Business Wire)
|
|
|
LONDON--(BUSINESS WIRE)--$LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced the election of Jette Nygaard-Andersen to the Company's Board of Directors after its Annual General Meeting of shareholders on June 10.
“We're pleased to welcome Jette to LivaNova's Board,” said William Kozy, Chair. “She brings deep medtech governance expertise, proven CEO leadership, and a strong track record of transformation, strategic M&A, and digital innovation across complex global businesses. Her international and public company board experience will be a valuable addition to LivaNova.”
Nygaard-Andersen is a tenured executive and board chair with more than 25 years of leadership experience in highly regulated international businesses. She is currently Chair of the Board for Coloplast A/S, a global medical device company based in Denmark. She has served as a Non-Executive Director of Coloplast since 2015, including as Chair of its Remuneration and Nomination Committee a...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
